GlassScriptPhysician profile
Katrina Maier
NPI 1316699374
$1,609.64
in general payments reported to CMS, 2019-2025
18 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $254 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,510 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,509.65 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $329.92 | 2024-2025 | Zoryve |
| Janssen Biotech, INC. | $274.19 | 2025 | Tremfya |
| Abbvie INC. | $228.48 | 2024-2025 | |
| Genzyme Corporation | $195.53 | 2025 | |
| Revance Therapeutics, INC. | $135.82 | 2025 | Daxxify |
| Lilly USA, LLC | $83.63 | 2024 | Ebglyss |
| Sun Pharmaceutical Industries INC. | $79.75 | 2025 | |
| Galderma Laboratories, L.P. | $39.86 | 2024-2025 | Dysport |
| Biofrontera INC. | $37.96 | 2025 | Ameluz |
| Organon LLC | $26.69 | 2025 | Vtama |
| Verrica Pharmaceuticals INC. | $26.34 | 2024 | Ycanth |
| Regeneron Healthcare Solutions, INC. | $25.85 | 2025 | Libtayo |
| Ucb, INC. | $25.35 | 2025 | Bimzelx |
| Botanix Sb INC | $23.33 | 2025 | Sofdra |
| Kerecis Limited | $20.67 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.06 | 2025 | |
| Lnhc, INC | $18.80 | 2025 | Zelsuvmi |
| Almirall LLC | $17.41 | 2025 | Seysara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Maier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.